Trade Sight Sciences, Inc. - SGHT CFD
Market information is presented
as of 2023-09-21
- Summary
| Spread | - | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Sight Sciences Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
| Prev. Close* | N/A |
| Open* | N/A |
| 1-Year Change* | N/A |
| Day's Range* | N/A |
| 52 wk Range | 5.35-15.30 |
| Average Volume (10 days) | 142.88K |
| Average Volume (3 months) | 2.46M |
| Market Cap | 305.53M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 48.65M |
| Revenue | 81.52M |
| EPS | -1.47 |
| Dividend (Yield %) | N/A |
| Beta | -100.00K |
| Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
Sight Sciences, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 71.331 | 48.956 | 27.64 | 23.348 | 7.53 |
| Revenue | 71.331 | 48.956 | 27.64 | 23.348 | 7.53 |
| Cost of Revenue, Total | 12.361 | 8.61 | 9.209 | 6.544 | 2.338 |
| Gross Profit | 58.97 | 40.346 | 18.431 | 16.804 | 5.192 |
| Total Operating Expense | 155.285 | 100.434 | 59.828 | 47.387 | 21.827 |
| Selling/General/Admin. Expenses, Total | 120.065 | 76.19 | 41.745 | 32.719 | 14.063 |
| Research & Development | 22.859 | 15.634 | 8.874 | 8.124 | 5.426 |
| Operating Income | -83.954 | -51.478 | -32.188 | -24.039 | -14.297 |
| Interest Income (Expense), Net Non-Operating | -4.466 | -4.366 | -2.373 | -1.787 | 0.001 |
| Other, Net | 2.225 | -6.928 | -0.071 | -0.035 | 0 |
| Net Income Before Taxes | -86.195 | -62.772 | -34.632 | -25.861 | -14.296 |
| Net Income After Taxes | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Net Income Before Extra. Items | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Net Income | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Income Available to Common Excl. Extra. Items | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Income Available to Common Incl. Extra. Items | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Diluted Net Income | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Diluted Weighted Average Shares | 47.8491 | 26.7341 | 45.0605 | 45.0605 | 45.0605 |
| Diluted EPS Excluding Extraordinary Items | -1.80238 | -2.35504 | -0.76992 | -0.5741 | -0.31713 |
| Diluted Normalized EPS | -1.80238 | -2.35504 | -0.76992 | -0.5741 | -0.31713 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 23.471 | 18.824 | 20.543 | 18.677 | 17.229 |
| Revenue | 23.471 | 18.824 | 20.543 | 18.677 | 17.229 |
| Cost of Revenue, Total | 3.381 | 3.048 | 3.665 | 2.928 | 2.736 |
| Gross Profit | 20.09 | 15.776 | 16.878 | 15.749 | 14.493 |
| Total Operating Expense | 38.658 | 36.392 | 37.596 | 40.522 | 40.093 |
| Selling/General/Admin. Expenses, Total | 30.056 | 28.675 | 28.698 | 31.541 | 31.431 |
| Research & Development | 5.221 | 4.669 | 5.233 | 6.053 | 5.926 |
| Operating Income | -15.187 | -17.568 | -17.053 | -21.845 | -22.864 |
| Interest Income (Expense), Net Non-Operating | -1.349 | -1.276 | -1.223 | -1.131 | -1.065 |
| Other, Net | 1.79 | 1.791 | 1.379 | 0.766 | 0.095 |
| Net Income Before Taxes | -14.746 | -17.053 | -16.897 | -22.21 | -23.834 |
| Net Income After Taxes | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 |
| Net Income Before Extra. Items | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 |
| Net Income | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 |
| Income Available to Common Excl. Extra. Items | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 |
| Income Available to Common Incl. Extra. Items | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 |
| Diluted Net Income | -14.754 | -17.067 | -16.907 | -22.229 | -23.843 |
| Diluted Weighted Average Shares | 48.5363 | 48.4053 | 48.2097 | 47.9105 | 47.7015 |
| Diluted EPS Excluding Extraordinary Items | -0.30398 | -0.35259 | -0.3507 | -0.46397 | -0.49984 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.30398 | -0.35259 | -0.3507 | -0.46397 | -0.49984 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 209.677 | 277.035 | 70.633 | 28.001 | 7.164 |
| Cash and Short Term Investments | 185 | 260.687 | 61.511 | 21.237 | 4.242 |
| Cash & Equivalents | 185 | 260.687 | 61.511 | 21.237 | 4.242 |
| Total Receivables, Net | 15.148 | 8.709 | 5.363 | 4.094 | 1.815 |
| Accounts Receivable - Trade, Net | 15.148 | 8.709 | 5.363 | 4.094 | 1.815 |
| Total Inventory | 6.114 | 3.475 | 2.598 | 2.244 | 0.486 |
| Prepaid Expenses | 3.415 | 4.164 | 1.161 | 0.426 | 0.621 |
| Total Assets | 213.073 | 280.186 | 72.806 | 30.741 | 8.094 |
| Property/Plant/Equipment, Total - Net | 3.185 | 2.949 | 1.787 | 2.572 | 0.868 |
| Property/Plant/Equipment, Total - Gross | 4.619 | 4.153 | 2.53 | 2.922 | 0.958 |
| Accumulated Depreciation, Total | -1.434 | -1.204 | -0.743 | -0.35 | -0.09 |
| Other Long Term Assets, Total | 0.211 | 0.202 | 0.386 | 0.168 | 0.062 |
| Total Current Liabilities | 17.817 | 13.504 | 9.314 | 7.336 | 2.896 |
| Accounts Payable | 2.688 | 3.351 | 2.158 | 2.315 | 1.879 |
| Accrued Expenses | 15.129 | 10.153 | 7.156 | 5.021 | 1.017 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 52.997 | 48.079 | 44.324 | 21.168 | 2.903 |
| Total Long Term Debt | 33.313 | 32.656 | 31.955 | 12.855 | 0 |
| Long Term Debt | 33.313 | 32.656 | 31.955 | 12.855 | 0 |
| Other Liabilities, Total | 1.867 | 1.919 | 3.055 | 0.977 | 0.007 |
| Total Equity | 160.076 | 232.107 | 28.482 | 9.573 | 5.191 |
| Redeemable Preferred Stock | 117.331 | 64.256 | 34.153 | ||
| Common Stock | 0.048 | 0.048 | 0.009 | 0.009 | 0.009 |
| Additional Paid-In Capital | 399.271 | 385.06 | 1.183 | 0.656 | 0.508 |
| Retained Earnings (Accumulated Deficit) | -239.243 | -153.001 | -90.041 | -55.348 | -29.479 |
| Total Liabilities & Shareholders’ Equity | 213.073 | 280.186 | 72.806 | 30.741 | 8.094 |
| Total Common Shares Outstanding | 48.2981 | 47.5047 | 45.0605 | 45.0605 | 45.0605 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 193.652 | 209.677 | 222.343 | 237.546 | 255.31 |
| Cash and Short Term Investments | 167.335 | 185 | 199.819 | 220.097 | 238.586 |
| Cash & Equivalents | 167.335 | 185 | 199.819 | 220.097 | 238.586 |
| Total Receivables, Net | 16.357 | 15.148 | 12.593 | 10.474 | 9.949 |
| Accounts Receivable - Trade, Net | 16.357 | 15.148 | 12.593 | 10.474 | 9.949 |
| Total Inventory | 7.138 | 6.114 | 5.52 | 4.94 | 4.082 |
| Prepaid Expenses | 2.822 | 3.415 | 4.411 | 2.035 | 2.693 |
| Total Assets | 196.641 | 213.073 | 225.234 | 240.749 | 258.59 |
| Property/Plant/Equipment, Total - Net | 2.765 | 3.185 | 2.689 | 2.967 | 3.089 |
| Property/Plant/Equipment, Total - Gross | 4.144 | 4.619 | 4.052 | 4.508 | 4.463 |
| Accumulated Depreciation, Total | -1.379 | -1.434 | -1.363 | -1.541 | -1.374 |
| Other Long Term Assets, Total | 0.224 | 0.211 | 0.202 | 0.236 | 0.191 |
| Total Current Liabilities | 15.145 | 17.817 | 17.386 | 14.197 | 12 |
| Accounts Payable | 3.501 | 2.688 | 3.239 | 2.725 | 3.074 |
| Accrued Expenses | 11.644 | 15.129 | 14.147 | 11.472 | 8.926 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 50.265 | 52.997 | 52.295 | 48.99 | 46.679 |
| Total Long Term Debt | 33.457 | 33.313 | 33.158 | 32.984 | 32.817 |
| Long Term Debt | 33.457 | 33.313 | 33.158 | 32.984 | 32.817 |
| Other Liabilities, Total | 1.663 | 1.867 | 1.751 | 1.809 | 1.862 |
| Total Equity | 146.376 | 160.076 | 172.939 | 191.759 | 211.911 |
| Redeemable Preferred Stock | |||||
| Common Stock | 0.048 | 0.048 | 0.048 | 0.048 | 0.048 |
| Additional Paid-In Capital | 402.638 | 399.271 | 395.227 | 391.818 | 388.127 |
| Retained Earnings (Accumulated Deficit) | -256.31 | -239.243 | -222.336 | -200.107 | -176.264 |
| Total Liabilities & Shareholders’ Equity | 196.641 | 213.073 | 225.234 | 240.749 | 258.59 |
| Total Common Shares Outstanding | 48.4504 | 48.2981 | 48.0833 | 47.8197 | 47.5904 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -86.242 | -62.96 | -34.693 | -25.869 | -14.29 |
| Cash From Operating Activities | -75.965 | -52.54 | -32.174 | -24.997 | -14.475 |
| Cash From Operating Activities | 0.71 | 0.632 | 0.554 | 0.295 | 0.063 |
| Non-Cash Items | 15.263 | 14.113 | 1.181 | 0.918 | 0.11 |
| Changes in Working Capital | -5.696 | -4.325 | 0.784 | -0.341 | -0.358 |
| Cash From Investing Activities | -0.97 | -0.813 | -0.953 | -0.672 | -0.57 |
| Capital Expenditures | -0.97 | -0.813 | -0.953 | -0.672 | -0.57 |
| Cash From Financing Activities | 1.248 | 252.529 | 73.401 | 42.664 | 12.203 |
| Financing Cash Flow Items | 0 | -4.506 | -0.509 | -2.116 | -0.046 |
| Issuance (Retirement) of Stock, Net | 1.248 | 257.035 | 53.43 | 30.78 | 12.249 |
| Issuance (Retirement) of Debt, Net | 0 | 20.48 | 14 | 0 | |
| Net Change in Cash | -75.687 | 199.176 | 40.274 | 16.995 | -2.842 |
| Cash Interest Paid | 3.252 | 3.105 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -17.067 | -86.242 | -69.335 | -47.106 | -23.263 |
| Cash From Operating Activities | -17.383 | -75.965 | -60.463 | -40.271 | -21.966 |
| Cash From Operating Activities | 0.146 | 0.71 | 0.557 | 0.375 | 0.179 |
| Non-Cash Items | 3.737 | 15.263 | 11.179 | 7.352 | 3.25 |
| Changes in Working Capital | -4.199 | -5.696 | -2.864 | -0.892 | -2.132 |
| Cash From Investing Activities | -0.126 | -0.97 | -0.841 | -0.569 | -0.227 |
| Capital Expenditures | -0.126 | -0.97 | -0.841 | -0.569 | -0.227 |
| Cash From Financing Activities | -0.156 | 1.248 | 0.436 | 0.25 | 0.092 |
| Financing Cash Flow Items | -0.205 | 0 | 0 | 0 | 0 |
| Issuance (Retirement) of Stock, Net | 0.049 | 1.248 | 0.436 | 0.25 | 0.092 |
| Net Change in Cash | -17.665 | -75.687 | -60.868 | -40.59 | -22.101 |
| Cash Interest Paid | 1.002 | 3.252 | 2.35 | 1.548 | 0.766 |
| Issuance (Retirement) of Debt, Net |
Sight Sciences, Inc. Company profile
About Sight Sciences Inc
Sight Sciences, Inc. is an ophthalmic medical device company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company’s surgical glaucoma product portfolio features the OMNI surgical system (OMNI), a device that facilitates the performance of both trabeculotomy and canaloplasty with a single device and single corneal incision. Its nonsurgical dry eye product portfolio consists of the TearCare system for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids. The Company has two reportable segments: Surgical Glaucoma and Dry Eye. Its Surgical Glaucoma segment consists of sales of the OMNI surgical system. Its Dry Eye segment includes sales of the TearCare system and related components and accessories. The Company primarily sell both the systems through a direct sales model.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Sight Sciences Inc revenues increased 84% to $34.3M. Net loss increased 84% to $47M. Revenues reflect Surgical Glaucoma segment increase of 88% to $32.6M, Dry Eye segment increase of 24% to $1.7M. Higher net loss reflects Selling, general, and administrative increase from $18.2M to $50.3M (expense), Research and development - Balancing val increase from $3.8M to $11M (expense).
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
3000 Sand Hill Road
Building 3, Suite 105
MENLO PARK
CALIFORNIA 94025
US
News
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com